Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...

Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly ...

Telangana IT and Industry Minister D Sridhar Babu has said innovation can start anywhere, from Hyderabad or a remote village in the state, and not necessarily from the Silicon Valley all the time.

India's Divi's Laboratories reported first-quarter profit below estimates on Wednesday, as manufacturers producing generic ...

In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 drugs like Ozempic, Eli Lilly has said., Health, Times Now ...

Recent health developments include the resolution of a saline shortage by the US FDA, delays in a Trump-era health commission ...

Lupin launches Glucagon for Injection USP in emergency kit, bioequivalent to Eli Lilly's product, with $122M annual sales.

Eli Lilly reports strong Q2 2025 growth, driven by Mounjaro & Zepbound. Highlights include increased guidance, pipeline updates, and key clinical milestones.

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

In July 2025 alone, Wegovy clocked Rs 7 crore in sales with around 5,000 injections, while Mounjaro posted Rs 47 crore in ...

Private equity firms are pushing their portfolio companies to set up Global Capability Centres (GCCs) in India, reports The Economic Times.